Xenophon Kassianides Selected Research

Chronic Renal Insufficiency

2/2024	The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD - the exploratory randomized controlled double-blind ExplorIRON-CKD study.
10/2023	Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD.
1/2023	Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease.
12/2022	Markers of Oxidative Stress, Inflammation and Endothelial Function following High-Dose Intravenous Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease-A Pooled Analysis.
2/2022	The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia.
1/2022	Analysis of oxidative stress, inflammation and endothelial function following intravenous iron in chronic kidney disease in the Iron and Heart Trial.
3/2021	The comparative effects of intravenous iron on oxidative stress and inflammation in patients with chronic kidney disease and iron deficiency: a randomized controlled pilot study.
1/2021	An evaluation of ferric derisomaltose as a treatment for anemia.
1/2021	Improving the safety of intravenous iron treatments for patients with chronic kidney disease.
1/2020	Correction to: Protocol and baseline data for a prospective open-label explorative randomized singlecenter comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xenophon Kassianides Research Topics

Disease

10	Chronic Renal Insufficiency 02/2024 - 01/2020
7	Iron Deficiencies 02/2024 - 01/2021
5	Anemia 02/2024 - 01/2021
4	Hypophosphatemia 02/2024 - 01/2021
4	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2023 - 01/2021
3	Inflammation (Inflammations) 12/2022 - 03/2021
2	Familial Hypophosphatemia (Phosphate Diabetes) 02/2024 - 01/2023
1	Fatigue 10/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Heart Failure 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Iron Overload 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2018

Drug/Important Bio-Agent (IBA)

11	IronIBA 02/2024 - 01/2020
6	ferric derisomaltoseIBA 10/2023 - 01/2021
4	Transferrin (beta 2 Transferrin)IBA 02/2024 - 01/2022
3	Ferritins (Ferritin)IBA 02/2024 - 01/2023
3	ferric carboxymaltoseIBA 10/2023 - 01/2021
2	Phosphates (Orthophosphate)IBA 02/2024 - 01/2023
2	Fibroblast Growth Factor-23IBA 02/2024 - 01/2023
2	Iron CompoundsIBA 01/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2021
1	Parathyroid Hormone (Parathormone)IBA 02/2024
1	Vitamin D FDA LinkGeneric 02/2024
1	C-Reactive ProteinIBA 12/2022
1	P-SelectinIBA 12/2022
1	E-SelectinIBA 12/2022
1	InterleukinsIBA 12/2022
1	thiobarbituric acidIBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022
1	Dextrans (Dextran)FDA Link 03/2021
1	Saccharated Ferric Oxide (Venofer)FDA Link 03/2021

Therapy/Procedure

1	Therapeutics 01/2021
1	Perioperative Care 01/2021
1	Metastasectomy 01/2018